PGSP-Stanford PsyD Consortium, Palo Alto University, Palo Alto, CA 94304, USA.
Department of Psychiatry & Behavioral Sciences, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Int J Environ Res Public Health. 2024 Jan 25;21(2):131. doi: 10.3390/ijerph21020131.
Smoking causes one in three cancer deaths and may worsen COVID-19 outcomes. Telehealth tobacco cessation treatment is offered as a covered benefit for patients at the Stanford Cancer Center. We examined predictors of engagement during the COVID-19 pandemic. Data were abstracted from the Electronic Health Record between 3/17/20 (start of pandemic shelter-in-place) and 9/20/22, including patient tobacco use, demographics, and engagement in cessation treatment. Importance of quitting tobacco was obtained for a subset (53%). During the first 2.5 years of the pandemic, 2595 patients were identified as recently using tobacco, and 1571 patients were contacted (61%). Of the 1313 patients still using tobacco (40% women, mean age 59, 66% White, 13% Hispanic), 448 (34%) enrolled in treatment. Patient engagement was greater in pandemic year 1 (42%) than in year 2 (28%) and year 3 (19%). Women (41%) engaged more than men (30%). Patients aged 36-45 (39%), 46-55 (43%), 56-65 (37%), and 66-75 (33%) engaged more than patients aged 18-35 (18%) and >75 (21%). Hispanic/Latinx patients (42%) engaged more than non-Hispanic/Latinx patients (33%). Engagement was not statistically significantly related to patient race. Perceived importance of quitting tobacco was significantly lower in pandemic year 1 than year 2 or 3. Nearly one in three cancer patients engaged in telehealth cessation treatment during the COVID-19 pandemic. Engagement was greater earlier in the pandemic, among women, Hispanic/Latinx individuals, and patients aged 36 to 75. Sheltering-in-place, rather than greater perceived risk, may have facilitated patient engagement in tobacco cessation treatment.
吸烟导致三分之一的癌症死亡，并可能使 COVID-19 的结果恶化。斯坦福癌症中心为患者提供远程医疗戒烟治疗作为一项涵盖的福利。我们研究了在 COVID-19 大流行期间参与治疗的预测因素。数据从电子健康记录中提取，时间范围为 2020 年 3 月 17 日（大流行居家令开始）至 2022 年 9 月 20 日，包括患者的烟草使用情况、人口统计学特征以及戒烟治疗的参与情况。对于一部分患者（53%）获得了戒烟的重要性。在大流行的头 2.5 年中，确定了 2595 名最近使用烟草的患者，并联系了 1571 名患者（61%）。在仍在使用烟草的 1313 名患者中（40%为女性，平均年龄 59 岁，66%为白人，13%为西班牙裔），有 448 名（34%）患者参加了治疗。在大流行的第一年（42%），患者的参与度高于第二年（28%）和第三年（19%）。女性（41%）的参与度高于男性（30%）。36-45 岁（39%）、46-55 岁（43%）、56-65 岁（37%）和 66-75 岁（33%）的患者比 18-35 岁（18%）和>75 岁（21%）的患者参与度更高。西班牙裔/拉丁裔患者（42%）的参与度高于非西班牙裔/拉丁裔患者（33%）。参与度与患者种族没有统计学上的显著关系。与 2 年或 3 年相比，大流行第一年患者戒烟的重要性明显降低。在 COVID-19 大流行期间，近三分之一的癌症患者接受了远程医疗戒烟治疗。在大流行早期、女性、西班牙裔/拉丁裔个体以及 36 至 75 岁的患者中，参与度更高。居家令而不是更大的感知风险可能促进了患者参与戒烟治疗。
